DOI 10.1016/j.jiac.2026.103016
Continuation of anti-tuberculosis therapy after Clostridioides difficile infection: a retrospective cohort study.
Аннотация
BACKGROUND
Clostridioides difficile infection (CDI) sometimes complicates tuberculosis (TB) treatment, but whether anti-TB therapy should be continued after CDI is unclear. We evaluated clinical outcomes according to whether anti-TB therapy was continued or discontinued after CDI onset.
METHODS
We retrospectively reviewed hospitalized TB patients who developed CDI at National Hospital Organization Tokyo National Hospital between January 2015 and March 2025. We compared clinical characteristics, CDI outcomes, and TB-related outcomes between patients who continued and those who discontinued anti-TB therapy after CDI diagnosis.
RESULTS
Among 3819 TB admissions, 47 patients met inclusion criteria. Median age was 85 years, and most CDI episodes were non-severe. Anti-TB therapy was continued in 32 patients (68.1%) and discontinued in 15 (31.9%). CDI treatment failure or recurrence was less frequent in the continuation group (6.3% vs 40%, p = 0.009). Time to sputum smear and culture conversion, length of stay, and in-hospital mortality did not differ between groups. Advanced age and impaired renal function were associated with CDI treatment failure or recurrence.
CONCLUSION
In this cohort, continuing anti-TB therapy after CDI diagnosis was not associated with worse CDI outcomes and may be feasible in patients with a favorable risk profile.
Предметные рубрики MeSH
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.